RESUMEN

El síndrome de apnea obstructiva del sueño es un problema mundial de salud pública; afecta alrededor del 3% de la población, se asocia a serias complicaciones, y genera elevados costos a los sistemas de salud. En este artículo revisamos aspectos generales de esta enfermedad y hacemos énfasis en la contribución que debe tener el neumólogo ante este problema masivo de salud pública que está directamente relacionado a la epidemia de obesidad.

PALABRAS CLAVE

Apnea obstructiva del sueño, polisomnografía, monitores portátiles, presión positiva continua en la vía aérea.

REFERENCIAS

1. American Academy of Sleep Medicine. International classification of sleep disorders. Diagnostic and coding manual. 2nd ed. Westchester, Illinois: American Academy of Sleep Medicine; 2005:51.

2. Iber C, Ancoli-Israel S, Chesson A, Quan SF for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester, Illinois: American Academy of Sleep Medicine; 2007.

3. Kapur V, Blough DK, Sandblom RE, et ál. The medical cost of undiagnosed sleep apnea. Sleep 1999;22:749-55.

4. Ohayon MM, Guilleminault C, Priest RG, Caulet M. Snoring and breathing pauses during sleep: telephone interview surrey of a United Kingdom population sample. BMJ 1997;314:860-863.

5. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144-148.

6. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.

7. Hiestand D, Britz P, Goldman M, Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 Poll. Chest 2006;130:780-786.

8. Torre-Bouscoulet L, Vázquez-García JC, Muiño A, et ál; and PLATINO Group. Prevalence of sleep-related symptoms in four Latin American cities. J Clin Sleep Med 2008;4:579-585.

9. Palla A, Digiorgio M, Carpenè N, et ál. Sleep apnea in morbidly obese patients: prevalence and clinical predictivity. Respiration 2009;78:134-40.

10. Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med 1994;150(5 Pt 1):1279-1285.

11. Sakurai S, Cui R, Tanigawa T, Yamagishi K, Iso H. Alcohol consumption before sleep is associated with severity of sleep-disordered breathing among professional Japanese truck drivers. Alcohol Clin Exp Res 2007;31:2053-2058.

12. Steens RD, Pouliot Z, Millar TW, Kryger MH, George CF. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease. Sleep 1993;16:318-326.

13. Ye L, Pien GW, Weaver TE. Gender differences in the clinical manifestation of obstructive sleep apnea. Sleep Med 2009;10:1075-1084.

14. Block AJ, Wynne JW, Boysen PG. Sleep-disordered breathing and nocturnal oxygen desaturation in postmenopausal women. Am J Med 1980; 69:75-79.

15. Kripke DF, Ancoli-Israel S, Klauber MR, Wingard DL, Mason WJ, Mullaney DJ. Prevalence of sleep-disordered breathing in ages 40-64 years: a population-based survey. Sleep 1997;20:65-76.

16. Cistulli PA. Craniofacial abnormalities in obstructive sleep apnoea: implications for treatment. Respirology 1996;1:167-174.

17. West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006;61:945-050.

18. Davi´ MV, Dalle-Carbonare L, Giustina A, et ál. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 2008;159:533-540.

19. Kapor VK, Koepsell TD, deMaine J, Hert R, Sandblom RE, Psaty BM. Association of hypothyroidism and obstructive sleep apnea. Am J Respir Crit Care Med 1998;158(5 Pt 1):1379-1383.

20. Shipley JE, Schteingart DE, Tandon R, Starkman MN.Sleep architecture and sleep apnoea in patients with Cushing´s disease. Sleep 1992;15:514-518.

21. Cistulli PA, Grunstein RR, Sullivan CE. Effect of testosterone administration on upper airway collapsability during sleep. Am J Respir Crit Care Med 1994;149(2 Pt 1):530-2.

22. Lacasse Y, Godbout C, Sériès F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J 2002;19:499-503.

23. Mulgrew AT, Nasvadi G, Butt A, et ál. Risk and severity ofmotor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea. Thorax 2008; 63:536-541.

24. Lindberg E, Carter N, Gislason T, Janson C. Role of snoring and daytime sleepiness in occupational accidents. Am J Respir Crit Care Med 2001; 164:2031-2035.

25. Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 2005;28:1405-1411.

26. Archbold KH, Borghesani PR, Mahurin RK, Kapur VK, Landis CA. Neural activation patterns during working memory tasks and OSA disease severity: preliminary findings. J Clin Sleep Med 2009;5:21-27.

27. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984;108:373-376.

28. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-264.

29. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490-494.

30. Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991;338:1480-1484.

31. Carrillo-Alduenda JL, Arredondo-del Bosque FM, Reyes- Zúñiga M, et ál. Índice de funcionamiento miocárdico en pacientes con síndrome de apnea obstructiva del sueño. Neumol Cir Torax 2009;68:100-105.

32. Weitzenblum E, Krieger J, Apprill M, et ál. Daytime pulmonaryhypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988;138:345-349.

33. Palomäki H, Partinen M, Erkinjuntti T, Kaste M. Snoring, sleep apnea syndrome, and stroke. Neurology 1992;42(7 Suppl 6):75-82.

34. Pérez-Padilla R. Síndrome de apnea obstructiva durante el sueño: fisiopatología y datos epidemiológicos. En: Valencia M, Salín R, Pérez-Padilla R, editores. Trastornos del dormir. México: McGraw-Hill; 2000.p. 259-271.

35. Woodson BT, Franco R. Physiology of sleep disordered breathing. Otolaryngol Clin North Am 2007;40:691-711.

36. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992;89:1571-1579.

37. Heinzer RC, Stanchina ML, Malhotra A, et ál. Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:114-117.

38. White DP. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 2005;172:1363-1370.

39. White DP. Sleep apnea. Proc Am Thorac Soc 2006;3:124- 128.

40. Isono S, Remmers JE, Tanaka A, Sho Y, Sato J, Nishino T. Anatomy of the pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol 1997;82:1319-1326.

41. van Lunteren E. Muscles of the pharynx: structural and contractile properties. Ear Nose Throat J 1993;72:27-29.

42. Martin SE, Marshall I, Douglas NJ. The effect of posture on airway caliber with sleep-apnea/hypopnea syndrome. Am J Respir Crit Care Med 1995; 152:721-724.

43. Mezzanotte WS, Tangel DJ, White DP. Influence of sleep onset on upper-airway muscle activity in apnea patients versus normal controls. Am J Respir Crit Care Med 1996;153(6 Pt 1):1880-1887.

44. Liistro G, Stănescu DC, Veriter C, Rodenstein DO, D’Odemont JP. Upper airway anesthesia induces airflow limitation in awake humans. Am Rev Respir Dis 1992;146:581-585.

45. Deegan PC, Nolan P, Carey M, McNicholas WT. Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol 1996;81:470-479.

46. van der Touw T, Crawford AB, Wheatley JR. Effects of a synthetic lung surfactant on pharyngeal patency in awake human subjects. J Appl Physiol 1997;82:78-85.

47. Torre-Bouscoulet L, Meza-Cargas MS, Castorena- Maldonado A, Pérez-Padilla R. Riesgo cardiovascular en adultos con síndrome de apnea obstructiva del sueño. A 25 años de los primeros estudios de asociación. Gac Méd Mex 2008;144:323-332.

48. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflamatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-2667.

49. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et ál. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-2464.

50. Tauman R, Ivanenko A, O´Brien LM, Gozal D. Plasma C-reactive protein levels among children with sleepdisordered breathing. Pediatrics 2004; 113:e564-e569.

51. Minoguchi K, Tazaki T, Yokoe T, et ál. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004;126:1473-1479.

52. Yokoe T, Minoguchi K, Matsuo H, et ál. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107:1129-1134.

53. McNicholas WT, Bonsignore MR; and Management Committee of EU COST B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-178.

54. Robinson GV, Pepperell JC, Segal HC, Davies RJ, StradlingJR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomized controlled trials. Thorax 2004;59:777-782.

55. Shitrit D, Peled N, Shitrit AB, et ál. An association between oxygen desaturation and D-dimer in patients with obstructive sleep apnea syndrome. Thromb Haemost 2005;94:544-547.

56. von Känel R, Loredo JS, Powell FL, Adler KA, Dimsdale JE. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin Hemorheol Microcirc 2005;33:369-377.

57. Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005;104:92-96.

58. Hui DS, Ko FW, Fok JP, et ál. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004;125:1768- 1775.

59. Schulz R, Mahmoudi S, Hattar K, et ál. Enhanced releaseof superoxide from plymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000;162(2 Pt 1):566-570.

60. Dyugovskaya L, Lavie P, Lavie L. Increased adhesionmolecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934-939.

61. Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, Scharf SM. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 2005;172:915-920.

62. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004;27:123-128.

63. Xu W, Chi L, Row BW, et ál. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience 2004;126:313-323.

64. Veasey SC, Davis CW, Fenik P, et ál. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 2004;27:194-201.

65. Zhang G, Serrano F, Fenik P, et ál. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005;172:921-929.

66. Shiomi T, Guilleminault C, Stoohs R, Schnittger I. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest 1991;100:894-902.

67. Stoohs R, Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 1992;72:583-589.

68. Virolainen J, Ventilä M, Turto H, Kupari M. Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 1995;79:455-460.

69. Hanly P, Sasson Z, Zuberi N, Alderson M. Ventricular function in snorers and patients with obstructive sleep apnea. Chest 1992;102:100-105.

70. Bradley TD. Right and left ventricular functional impairment and sleep apnea. Clin Chest Med 1992;13:459-479.

71. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003;290:1906-1914.

72. Terán-Santos J, Jiménez-Gómez A, Cordero-Guevara J.The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med 1999;340:847-851.

73. Morgan BJ, Crabtree DC, Puleo DS, Badr MS, Toiber F, Skatrud JB. Neurocirculatory consequences of abrupt change in sleep state in humans. J Appl Physiol 1996;80:1627-1636.

74. Narkiewicz K, Montano N, Cugliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998;98:1071-1077.

75. Kryger M, Roth T, Dement W. Principles and practice of sleep medicine. 3rd ed. Filadelfia: Saunders; 2000.p.869-878.

76. Hoffstein V, Szalai JP. Predictive value of clinical features in diagnosing obstructive sleep apnea. Sleep 1993;16:118-122.

77. Ward Flemons W, McNicholas WT. Clinical prediction of the sleep apnea syndrome. Sleep Med Rev 1997;1:19-32.

78. Moriyama Y, Miwa K, Tanaka H, Fujihiro S, Nishino Y, Deguchi T. Nocturia in men less than 50 years of age may be associated with obstructive sleep apnea syndrome. Urology 2008;71:1096-1098.

79. Viera AJ, Bond MM, Yates SW. Diagnosing night sweats. Am Fam Physician 2003;67:1019-1024.

80. Iriarte J, Murie-Fernández M, Toledo E, et ál. Sleep structure in patients with periodic limb movements and obstructive sleep apnea syndrome. J Clin Neurophysiol 2009;26:267-271.

81. Karkos PD, Leong SC, Benton J, Sastry A, AssimakopoulosD, Issing WJ. Reflux and sleeping disorders: a systematic review. J Laryngol Otol 2009; 123:372-374.

82. Chica-Urzula H, Escobar-Córdoba F, Eslava-Schmalbach J. Validación de la escala de somnolencia de Epworth. Rev Salud Pública 2007;9:558-567.

83. Goksan B, Gunduz A, Karadeniz D, et ál. Morning headache in sleep apnoea: clinical and polysomnographic evaluation and response to nasal continuous positive airway pressure. Cephalalgia 2009;29:635-641.

84. Hanak V, Jacobson DJ, McGree ME, et ál. Snoring as a risk factor for sexual dysfunction in community men. J Sex Med 2008;5:898-908.

85. Harris M, Glozier N, Ratnavadivel R, Grunstein RR. Obstructive sleep apnea and depression. Sleep Med Rev 2009;13:437-444.

86. Bardwell WA, Ancoli-Israel S, Dimsdale JE. Comparison of the effects of depressive symptoms and apnea severity on fatigue in patients with obstructive sleep apnea: a replication study. J Affect Disord 2007;97:181-186.

87. Jennum P, Sjøl A. Self-assessed cognitive function in snorers and sleep apneics. An epidemiological study of 1,504 females and males aged 30-60 years: the Dan- MONICA II Study. Eur Neurol 1994;34:204-208.

88. Haponik EF, Smith PL, Meyers DA, Bleecker ER. Evaluation of sleep-disordered breathing. Is polysomnography necessary? Am J Med 1984;77: 671-677.

89. Flemons WW. Clinical practice. Obstructive sleep apnea. N Engl J Med 2002;347:498-504.

90. Kushida CA, Littner MR, Morgenthaler T, et ál. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;4:499-519.

91. Kushida CA, Littner MR, Hirshkowitz M, et ál. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006;29:375- 380.

92. Ross SD, Sheinhait IA, Harrison KJ, et ál. Systematic review and meta-analysis of the literature regarding the diagnosis of sleep apnea. Sleep 2000;23:519-532.

93. Collop NA, Anderson WM, Boehlecke B, et ál. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adults patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007;3:737-477.

94. Bridevaux PO, Fitting JW, Fellrath JM, Aubert JD. Interobserver agreement on apnoea hypopnoea index using portable monitoring of respiratory parameters. Swiss Med Wkly 2007;137:602-607.

95. Torre-Bouscoulet L, Castorena-Maldonado A, Baños- Flores R, Vázquez-García JC, Meza-Vargas MS, Pérez-Padilla R. Agreement between oxygen desaturation index and apnea-hypopnea index in adults with suspected obstructive sleep apnea at an altitude of 2240 m. Arch Bronconeumol 2007; 43:649-654.

96. Smith LA, Chong BW, Vennelle M, Denvir MA, Newby DE, Douglas NJ. Diagnosis of sleep-disordered breathing in patients with chronic heart failure: evaluation of a portable limited study system. J Sleep Res 2007;16: 428-435.

97. Kirk VG, Flemons WW, Adams C, Rimmer KP, Montgomery MD. Sleep- disordered breathing in duchenne muscular dystrophy: a preliminary study of the role of portable monitoring. Pediatr Pulmonol 2000;29:135-140.

98. Mulgrew AT, Fox N, Ayas NT, Ryan CF. Diagnosis and Initial Management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann Intern Med 2007;146:157-166.

99. Yin M, Miyazaki S, Ishikawa K. Evaluation of type 3 portable monitoring in unattended home setting for suspected sleep apnea: factors that may affect its accuracy. Otolaryngol Head Neck Surg 2006;134:204-209.

100. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-3021.

101. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994;154:2219-2224.

102. Scanlan MF, Roebuck T, Little PJ, Redman JR, Naughton MT. Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J 2000;16: 909-913.

103. Mendelson WB, Garnett D, Gillin JC. Flurazepam-induced sleep apnea syndrome in a patient with insomnia an mild sleep-related respiratory changes. J Nerv Ment Dis 1981;169:261-264.

104. Kraiczi H, Hedner J, Dahlöf P, Ejnell H, Carlson J. Effects of serotonin uptake inhibition on breathing during sleep and daytime symptoms in sleep apnea. Sleep 1999;22:61-67.

105. Smith PL, Haponik EF, Allen RP, Bleecker ER. The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983;127:8-13.

106. Manber R, Kuo TF, Cataldo N, Colrain IM. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 2003;26:162-168.

107. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006;29:1036-1044.

108. Kushida CA, Morgenthaler TI, Littner MR, et ál. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 2006;29:240-243.

109. Lazard DS, Blumen M, Lévy P, et ál. The tongue-retaining device: efficacy and side effects in obstructive sleep apnea syndrome. J Clin Sleep Med 2009;15:431-438.

110. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;1:862- 865.

111. Kakkar RK, Berry RB. Positive airway pressure treatment for obstructive sleep apnea. Chest 2007;132:1057-1072.

112. Mathru M, Esch O, Lang J, et ál. Magnetic resonance imaging of the upper airway. Effects of propofol anesthesia and nasal continuous positive airway pressure in humans. Anesthesiology 1996;84:273-279.

113. Gay P, Weaver T, Loube D, Iber C. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006;29:381-401.

114. Littner M, Hirshkowitz M, Davila D, et ál. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medice report. Sleep 2002;25:143-147.

115. Masa JF, Jiménez A, Durán J, et ál. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med 2004;170:1218-1224.

116. Farré R, Montserrat JM, Rigau J, Trepat X, Pinto P, Navajas D. Response of automatic continuous positive airway pressure devices to different sleep breathing patterns: a bench study. Am J Respir Crit Care Med 2002;166:469-472.

117. Resta O, Guido P, Picca V, et ál. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two centre study. Respir Med 1998;92:820-827.

118. Torre-Bouscoulet L, López-Escárcega E, Castorena-Maldonado A, Vázquez-García JC, Meza-Vargas MS, Pérez- Padilla R. Continuous positive airway pressure used by adults with obstructive sleep apneas after prescription in a public referral hospital in Mexico city. Arch Bronconeumol 2007;43:16-21.

119. Nilius G, Happel A, Domanski U, Ruhle KH. Pressurerelief continuous positive airway pressure vs. constant continuous positive airway pressure: a comparison of efficacy and compliance. Chest 2006;130:1018-1024.

120. Leidag M, Hader C, Keller T, Meyer Y, Rasche K. Mask leakage in continuous positive airway pressure and CFlex. J Physiol Pharmacol 2008; 59 Suppl 6:401-406.

121. Marshall NS, Neill AM, Campbell AJ. Randomized trial of compliance with flexible (C-Flex) and standard continuous positive airway pressure for severe obstructive sleep apnea. Sleep Breath 2008;12:393-396.

122. Canisius S, Kesper K, Jerrentrop L, et ál. C-Flex technology effects on breathing parameters and inspiratory flow limitation. Respiration 2009; 78:168-176.

123. Won CH, Li KK, Guilleminault C. Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery. Proc Am Thorac Soc 2008;5:193-199.

124. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977;63:348-358.

125. Walker-Engström ML, Tegelberg A, Wilhelmsson B, Ringqvist I. 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002;121:739-746.

126. Millman RP, Carlisle CC, Rosenberg C, Kahn D, McRae R, Kramer NR. Simple predictors of uvulopalatopharyngoplasty outcome in the treatment of obstructive sleep apnea. Chest 2000;118:1025-1030.

127. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuos positive airway pressure: an observational study. Lancet 2005;365:1046-1053.

128. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuos positive airway pressure for obstructive sleep apnoea: a randomized prospective parallel trial. Lancet 1999;353:2100-2105.

129. Montserrat JM, Ferrer M, Hernández L, et ál. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001;164:608-613.

130. Parish JM, Lyng PJ. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest 2003;124:942-947.

131. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apneahypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001;164(8 Pt 1):1459-1463.

132. Becker HF, Jerrentrup A, Ploch T, et ál. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.

133. Sajkov D, Wang T, Saunders NA, Bune AJ, Mcevoy RD. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165: 152-158.

134. Harbison J, O´Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000;118:591-595.

135. Kanagala R, Morali NS, Friedman PA, et ál. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107:2589-2594.

136. Kaneko Y, Floras JS, Usui K, et ál. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-1241.

137. Findley L, Smith C, Hooper J, Dineen, Suratt PM. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 2000;161(3 Pt 1):857-859.

138. Gonçalves MA, Guilleminault C, Ramos E, Palha A, Paiva T. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med 2005;6:333-339.

139. Krieger J, Follenius M, Sforza E, Brandenberger G, Peter JD. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond)1991;80:443-449.

140. Cuhadaroğlu C, Utkusavaş A, Oztürk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulina resistance, lipido profile, and plasma leptin in sleep apnea. Lung 2009;187:75-81.

141. Dawson A, Abel SL, Loving RT, et ál. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 2008;4:538- 542.

142. Collop NA. Portable monitoring for the diagnosis of obstructive sleep apnea. Curr Opin Pulm Med 2008;14:525- 529.